Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.06 +0.04 (+4.04%)
As of: Oct 22, 2026 · 10:18 AM EDT

Cadrenal Therapeutics (CVKD) Total Non-Current Liabilities (2022 - 2023)

Updated

Cadrenal Therapeutics (CVKD) posted Total Non-Current Liabilities of -$3.55 million for Q4 2023, compared with $1.95 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Total Non-Current Liabilities (2022 - 2023) Analysis & Trends

  • In prior years, Cadrenal Therapeutics' Total Non-Current Liabilities was $1.95 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn 105.50 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn 106.45 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn 33.91 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.10 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 97.04 Bn
10 Cadrenal Therapeutics 3.09 Mn -9.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -3.55 Mn
Dec 31, 2022 1.95 Mn
API Access

Cadrenal Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CVKD&period=max&api_key=YOUR_API_KEY